• A Headlands Research Site   
    Headlands Research White Logo
    • About Headlands Research
    • Capabilities
    • Site Network
    • Team
Toronto Memory Program
  • Facebook
  • Twitter
  • LinkedIn
Donate Now
  • About Us
    • Medical Director
    • Our Team
    • Our Facility
    • Careers
  • Patients
    • Memory Clinic
    • Movement Disorders Clinic
    • Free Memory Assessment
    • Frequently Asked Questions
    • Clinical Trials
  • Physicians
  • Sponsors
  • Clinical Trials
    • Current Studies
    • Free Memory Assessment
    • Frequently Asked Questions
    • Diversity & Inclusion
  • Media
  • Contact

Media

 

An experimental Alzheimer’s drug could be approved next year. But it comes with risks

An experimental Alzheimer's drug could be approved next year. But it comes with risks

Researchers say the experimental Alzheimer's drug Lecanemab represents an important advance and is likely to get FDA approval in 2023, despite some safety concerns.

To read more, click on the link below.

https://www.npr.org/2022/12/06/1140894394/an-experimental-alzheimers-drug-could-be-approved-next-year-but-it-comes-with-ri

Recent Posts

  • Hope and anxiety surround new Alzheimer’s drug lecanemab
  • Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns
  • A New Drug Could Slow Alzheimer’s Disease, Data Show
  • A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
  • An experimental Alzheimer’s drug could be approved next year. But it comes with risks
  • Ontario not ready for new Alzheimer’s treatment
  • Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC
  • Dr. Sharon Cohen on Medcan’s podcast series called Eat, Move, Think!
  • Dr. Sharon Cohen on CanadaTalks with Matt Gurney
  • CTV News Channel with Dr. Sharon Cohen on FDA approval of Aducanumab

Media Requests

If your organization would like to make a request, please use one of the following two options:

  • Call: (416) 386-9761 Ext. 364
  • Email: media@memorydisorders.ca
Latest Tweets
No feed found with the ID 1. Go to the All Feeds page and select an ID from an existing feed.

Toronto Memory Program

A Headlands Research Company

  • Facebook
  • Twitter
  • LinkedIn

1 Valleybrook Dr, North York, ON M3B 2S7, Canada

  • About Us
  • Patients
  • Physicians
  • Sponsors
  • Studies
  • In the Media
  • Contact Us


Monday - Friday: 8am - 4pm


Headlands Research Logo



© 2025 Toronto Memory Program. All rights reserved.

View Privacy Policy